Key Event Components

  • Key Event Components (KECs) are used to describe Key Events (KEs) in a computable way, by defining an action, processes, and object term that maps to controlled vocabulary and ontology terms.
  • KECs on this page can be filtered by the action, process, and object terms, as well as by source ontologies.
  • Link to source ontology terms are provided in cases where the URL was available when the ontology terms were added to the AOP-Wiki database.
  • A complete list of all KECs is available in TSV format on the Downloads Page.
Showing 326 to 350 of 1152 KECs
Clear Table Filters
ID Action Process Object Associated Key Events (KEs)
345 increased anesthesia (MESH:D000758) 634: N/A, sedation
352 increased 3',5'-cyclic AMP(1-) (CHEBI:58165) 693: Increased, cyclic adenosine monophosphate
359 increased deactivation of mitotic spindle assembly checkpoint (GO:1902426) MAD2 like protein (fruit fly) (PR:Q9VNE1) 695: Upregulated, Spindle assembly checkpoint protein Mad2-oocyte
361 increased Arrhythmias, Cardiac (MESH:D001145) 699: Increased, cardiac arrthymia
364 increased cell death (GO:0008219) kidney tubule cell (CL:1000507) 709: Increase, Cytotoxicity (renal tubular cell)
365 increased epithelial cell proliferation (GO:0050673) nephron tubule epithelial cell (CL:1000494) None
366 increased Adenoma (MESH:D000236)
367 increased Carcinoma (MESH:D002277)
368 increased hyperplasia (MESH:D006965) kidney tubule cell (CL:1000507) 767: Increase, Hyperplasia (renal tubular cells)
369 increased major urinary protein (rat) (PR:P02761) 708: Increased, Accumulation of alpha2u microglobulin (proximal tubular epithelium)
370 increased binding (GO:0005488) major urinary protein (rat) (PR:P02761) 714: Increased, Binding of chemicals to 2u (serum)
372 increased tubulin binding (GO:0015631) tubulin (PR:000028799) 718: Binding, Tubulin
373 increased microtubule depolymerization (GO:0007019) microtubule (GO:0005874) 720: Disruption, Microtubule dynamics
375 increased cell proliferation (GO:0008283) mitogenic signaling cell (CL:0000422) 716: Increase, cell proliferation (hepatocytes)
376 increased preneoplasia (MP:0002009) abnormal cell mass (MP:0003902) 774: Increase, Preneoplastic foci (hepatocytes)
378 increased cellular respiration (GO:0045333) 769: Increase, Oxidative metabolism
379 increased pyruvate dehydrogenase activity (GO:0004738) pyruvate dehydrogenase [ubiquinone] (PR:000023575) 726: Increased, Induction of pyruvate dehydrogenase (PDH)
381 increased cell death (GO:0008219) bronchial epithelial cell (CL:0002328) 733: Increase, Necrosis (terminal bronchiolar cells)
382 increased epithelial cell proliferation (GO:0050673) bronchial epithelial cell (CL:0002328) 734: Increase, Regenerative cell proliferation (terminal bronchiolar epithelial cells)
383 increased hyperplasia (MESH:D006965) bronchial epithelial cell (CL:0002328) 735: Increase, Hyperplasia (terminal bronchiolar cells)
384 increased cell death (GO:0008219) Clara cell (CL:0000158) 770: Increase, Cytotoxicity (club cells)
385 increased cell proliferation (GO:0008283) thyroid follicular cell (CL:0002258)
386 increased hypertrophy (MESH:D006984) thyroid follicular cell (CL:0002258)
387 increased hyperplasia (MESH:D006965) thyroid follicular cell (CL:0002258)
388 increased Thyroid stimulating hormone (CHEBI:81567)